Gupta SK, Keck J, Ram PK, Crump JA, Miller MA, Mintz ED, 2008. Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005. Epidemiol Infect 136: 721–738.
Okoh AI, Osode AN, 2008. Enterotoxigenic Escherichia coli (ETEC): a recurring decimal in infants' and travelers' diarrhea. Rev Environ Health 23: 135–148.
Valentiner-Branth P, Steinsland H, Fischer TK, Perch M, Scheutz F, Dias F, Aaby P, Molbak K, Sommerfelt H, 2003. Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol 41: 4238–4245.
Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H, 2010. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect 12: 89–98.
Nataro JP, Kaper JB, 1998. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142–201.
Steinsland H, Valentiner-Branth P, Gjessing HK, Aaby P, Molbak K, Sommerfelt H, 2003. Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study. Lancet 362: 286–291.
Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR, 2009. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol 191: 178–186.
Berkes J, Viswanathan VK, Savkovic SD, Hecht G, 2003. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439–451.
Guttman JA, Finlay BB, 2009. Tight junctions as targets of infectious agents. Biochim Biophys Acta 1788: 832–841.
Fullner KJ, Lencer WI, Mekalanos JJ, 2001. Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin. Infect Immun 69: 6310–6317.
Lencer WI, Constable C, Moe S, Rufo PA, Wolf A, Jobling MG, Ruston SP, Madara JL, Holmes RK, Hirst TR, 1997. Proteolytic activation of cholera toxin and Escherichia coli labile toxin by entry into host epithelial cells. Signal transduction by a protease-resistant toxin variant. J Biol Chem 272: 15562–15568.
Nataro JP, Hicks S, Phillips AD, Vial PA, Sears CL, 1996. T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis. Infect Immun 64: 4761–4768.
Chong C, Friberg M, Clements JD, 1998. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16: 732–740.
Harrington SM, Strauman MC, Abe CM, Nataro JP, 2005. Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol 7: 1565–1578.
Dickinson BL, Clements JD, 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63: 1617–1623.
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C, 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375: 1969–1987.
Prentice AM, Darboe MK, 2008. Growth and host-pathogen interactions. Nestle Nutr Workshop Ser Pediatr Program 61: 197–210.
Cromwell GL, 2002. Why and how antibiotics are used in swine production. Anim Biotechnol 13: 7–27.
Humphrey JH, 2009. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 374: 1032–1035.
Ramakrishna BS, Venkataraman S, Mukhopadhya A, 2006. Tropical malabsorption. Postgrad Med J 82: 779–787.
Lycke N, Karlsson U, Sjolander A, Magnusson KE, 1991. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol 33: 691–698.
Beltinger J, del Buono J, Skelly MM, Thornley J, Spiller RC, Stack WA, Hawkey CJ, 2008. Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. World J Gastroenterol 14: 7345–7352.
Bagley KC, Abdelwahab SF, Tuskan RG, Lewis GK, 2006. Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide. Clinical Vaccine Immunol 13: 106–115.
Rodriguez-Lagunas MJ, Martin-Venegas R, Moreno JJ, Ferrer R, 2010. PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monlayers. Am J Physiol Cell Physiol 299: C324–C334.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1014 | 927 | 31 |
Full Text Views | 414 | 23 | 4 |
PDF Downloads | 111 | 16 | 0 |
Enterotoxigenic Escherichia coli (ETEC) is a common cause of acute diarrhea in resource-poor settings. We report that some ETEC strains elicit a reduction in trans-epithelial electrical resistance (TER) in polarized T84 epithelial cell monolayers. The effect was irreversible up to 48 hours after a three-hour infection and was observed with heat-labile enterotoxin (LT)–producing strains, but not with heat-stable enterotoxin (ST)–producing strains. Using purified LT, a mutant with reduced ADP-ribosylating activity, and the LT-B subunit alone, we demonstrate that TER reduction requires a functional enterotoxin. Treatment of monolayers with LT or LT-producing strains of ETEC increases paracellular permeability to fluorescein isothiocyanate–dextran. Our data suggest that LT-producing ETEC strains may induce intestinal barrier dysfunction.
Financial support: This study was supported by grant AI33096 from the National Institutes of Health to Joseph P. Nataro.
Authors' addresses: Roderick B. Kreisberg, Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, E-mail: rkrei001@yahoo.com. Jill Harper, Maura C. Strauman, and Mark Marohn, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, E-mails: jharper@medicine.mumaryland.edu, mstrauman@wistar.org, and mmaro001@umaryland.edu. John D. Clements, Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, LA, E-mail: jclemen@tulane.edu. James P. Nataro, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, E-mail: jpn2r@virginia.edu.
Gupta SK, Keck J, Ram PK, Crump JA, Miller MA, Mintz ED, 2008. Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005. Epidemiol Infect 136: 721–738.
Okoh AI, Osode AN, 2008. Enterotoxigenic Escherichia coli (ETEC): a recurring decimal in infants' and travelers' diarrhea. Rev Environ Health 23: 135–148.
Valentiner-Branth P, Steinsland H, Fischer TK, Perch M, Scheutz F, Dias F, Aaby P, Molbak K, Sommerfelt H, 2003. Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol 41: 4238–4245.
Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H, 2010. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect 12: 89–98.
Nataro JP, Kaper JB, 1998. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142–201.
Steinsland H, Valentiner-Branth P, Gjessing HK, Aaby P, Molbak K, Sommerfelt H, 2003. Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study. Lancet 362: 286–291.
Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR, 2009. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol 191: 178–186.
Berkes J, Viswanathan VK, Savkovic SD, Hecht G, 2003. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439–451.
Guttman JA, Finlay BB, 2009. Tight junctions as targets of infectious agents. Biochim Biophys Acta 1788: 832–841.
Fullner KJ, Lencer WI, Mekalanos JJ, 2001. Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin. Infect Immun 69: 6310–6317.
Lencer WI, Constable C, Moe S, Rufo PA, Wolf A, Jobling MG, Ruston SP, Madara JL, Holmes RK, Hirst TR, 1997. Proteolytic activation of cholera toxin and Escherichia coli labile toxin by entry into host epithelial cells. Signal transduction by a protease-resistant toxin variant. J Biol Chem 272: 15562–15568.
Nataro JP, Hicks S, Phillips AD, Vial PA, Sears CL, 1996. T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis. Infect Immun 64: 4761–4768.
Chong C, Friberg M, Clements JD, 1998. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16: 732–740.
Harrington SM, Strauman MC, Abe CM, Nataro JP, 2005. Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol 7: 1565–1578.
Dickinson BL, Clements JD, 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63: 1617–1623.
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C, 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375: 1969–1987.
Prentice AM, Darboe MK, 2008. Growth and host-pathogen interactions. Nestle Nutr Workshop Ser Pediatr Program 61: 197–210.
Cromwell GL, 2002. Why and how antibiotics are used in swine production. Anim Biotechnol 13: 7–27.
Humphrey JH, 2009. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 374: 1032–1035.
Ramakrishna BS, Venkataraman S, Mukhopadhya A, 2006. Tropical malabsorption. Postgrad Med J 82: 779–787.
Lycke N, Karlsson U, Sjolander A, Magnusson KE, 1991. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol 33: 691–698.
Beltinger J, del Buono J, Skelly MM, Thornley J, Spiller RC, Stack WA, Hawkey CJ, 2008. Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. World J Gastroenterol 14: 7345–7352.
Bagley KC, Abdelwahab SF, Tuskan RG, Lewis GK, 2006. Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide. Clinical Vaccine Immunol 13: 106–115.
Rodriguez-Lagunas MJ, Martin-Venegas R, Moreno JJ, Ferrer R, 2010. PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monlayers. Am J Physiol Cell Physiol 299: C324–C334.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1014 | 927 | 31 |
Full Text Views | 414 | 23 | 4 |
PDF Downloads | 111 | 16 | 0 |